Laboratory of Veterinary Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763 Republic of Korea.
Toxicology. 2013 Mar 8;305:41-8. doi: 10.1016/j.tox.2012.12.021. Epub 2013 Jan 14.
2,4-Dihydroxybenzophenone (benzophenone-1; BP-1) is an UV stabilizer primarily used to prevent polymer degradation and deterioration in quality due to UV irradiation. Recently, BP-1 has been reported to bioaccumulate in human bodies by absorption through the skin and has the potential to induce health problems including endocrine disruption. In the present study, we examined the xenoestrogenic effect of BP-1 on BG-1 human ovarian cancer cells expressing estrogen receptors (ERs) and relevant xenografted animal models in comparison with 17-β estradiol (E2). In in vitro cell viability assay, BP-1 (10(-8)-10(-5)M) significantly increased BG-1 cell growth the way E2 did. The mechanism underlying the BG-1 cell proliferation was proved to be related with the up-regulation of cyclin D1, a cell cycle progressor, by E2 or BP-1. Both BP-1 and E2 induced cell growth and up-regulation of cyclin D1 were reversed by co-treatment with ICI 182,780, an ER antagonist, suggesting that BP-1 may mediate the cancer cell proliferation via an ER-dependent pathway like E2. On the other hand, the expression of p21, a regulator of cell cycle progression at G1 phase, was not altered by BP-1 though it was down-regulated by E2. In xenograft mouse models transplanted with BG-1 cells, BP-1 or E2 treatment significantly increased the tumor mass formation compared to a vehicle (corn oil) within 8 weeks. In histopathological analysis, the tumor sections of E2 or BP-1 group displayed extensive cell formations with high density and disordered arrangement, which were supported by the increased number of BrdUrd positive nuclei and the over-expression of cyclin D1 protein. Taken together, these results suggest that BP-1 is an endocrine disrupting chemical (EDC) that exerts xenoestrogenic effects by stimulating the proliferation of BG-1 ovarian cancer via ER signaling pathway associated with cell cycle as did E2.
2,4-二羟基二苯甲酮(二苯甲酮-1;BP-1)是一种紫外线稳定剂,主要用于防止聚合物因紫外线照射而降解和劣化。最近,有报道称 BP-1 可通过皮肤吸收在人体内蓄积,并有可能引发包括内分泌干扰在内的健康问题。在本研究中,我们研究了 BP-1 对表达雌激素受体(ER)的 BG-1 人卵巢癌细胞的类雌激素效应,并与 17-β 雌二醇(E2)进行了比较。在体外细胞活力测定中,BP-1(10(-8)-10(-5)M)显著增加了 BG-1 细胞的生长,其方式与 E2 相同。BG-1 细胞增殖的机制被证明与细胞周期进程促进剂 cyclin D1 的上调有关,E2 或 BP-1 均可上调 cyclin D1。BP-1 和 E2 诱导的细胞生长和 cyclin D1 的上调均被 ER 拮抗剂 ICI 182,780 共同处理所逆转,表明 BP-1 可能通过与 E2 类似的 ER 依赖途径介导癌细胞增殖。另一方面,BP-1 虽然下调了 E2,但并未改变 p21(G1 期细胞周期进程的调节剂)的表达。在移植 BG-1 细胞的异种移植小鼠模型中,与载体(玉米油)相比,BP-1 或 E2 处理在 8 周内显著增加了肿瘤质量的形成。在组织病理学分析中,E2 或 BP-1 组的肿瘤切片显示出广泛的细胞形成,密度高且排列紊乱,这得到了 BrdUrd 阳性核数增加和 cyclin D1 蛋白过表达的支持。综上所述,这些结果表明,BP-1 是一种内分泌干扰化学物质(EDC),通过与 E2 一样的 ER 信号通路刺激 BG-1 卵巢癌细胞的增殖,发挥类雌激素作用。